Fig. 1 HPV-attributable fractions for head and neck cancers according to positivity and/or over-expression of selected biomarkers of HPV-induced carcinogenesis Figure 2 shows oropharyngeal HPV-AFs by geography, gender, age group, and year of…
Reference Lesion No. of cases Method HPV-positivity Types detected Syrjänen et al. (1983a, b, c, d) SCC 40 ICH 8/40 20 % Syrjänen et al. (1983a, b, c, d) SCC 1…
Fig. 1 a Schematic overview of HPV infection and integration during the development of HPV-positive tumors (modified from Woodman et al. 2007; Cornet et al. 2015). HPV is thought to access…
Fig. 1 Motor and sensory direct cortical stimulation data. Rendering of left and right hemisphere positive stimulation sites eliciting movement (green) and dysesthesias (yellow) within the precentral and postcentral gyri, respectively….
Fig. 1 Age-standardized incidence rates of malignant brain tumors (males and females combined) per 100,000 persons in 2012 by country (GLOBOCAN) Fig. 2 Age-standardized incidence rates of malignant brain tumor per 100,000…
The goals of palliative care include: • Provides relief from pain and other distressing symptoms • Affirms life and regards dying as a normal process • Intends neither to hasten…
21. Gronych J, Korshunov A, Bageritz J, Milde T, Jugold M, Hambardzumyan D, Remke M, Hartmann C, Witt H, Jones DT, Witt O, Heiland S, Bendszus M, Holland EC, Pfister…
Class^ Median overall survival (months) 2-year survival (%) 1 58 76 2 37 68 3* 18 35 4* 11 15 5* 9 6 6* 4.5 4 Legend ^Class defined by…
Trial Patients (% GBM) Treatment Med. survival (months) P value BTSG 66-01 [4] 96 (85 %) No radiotherapy 3.5 <0.05 WBRT < 5000 cGy 7.7 WBRT ≥ 5000 cGy 8.4 BTSG 69-01 [3] 222 (90 %) No radiotherapy…
Trial Vaccine Type Phase Experimental design N PFS (mo) OS (mo) NCT00612001 [32] DC I Autologous DC + selected glioma antigens 6 9.6 18.1 NCT00846456 [59] DC I/II Autologous DC transfected with…
